证券代码：600055 证券简称：万东医疗 公告编号：2025-043 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管 指引第7号——回购股份》等相关规定，现将公司回购股份的进展情况公 告如下： 北京万东医疗科技股份有限公司 关于以集中竞价交易方式回购股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法 律责任。 重要内容提示： 回购方案首次披露日 2025/8/23 回购方案实施期限 2025 年 8 月 22 日~2026 年 8 月 21 日 预计回购金额 3,000万元~6,000万元 □减少注册资本 √用于员工持股计划或股权激励 回购用途 □用于转换公司可转债 □为维护公司价值及股东权益 累计已回购股数 0万股 累计已回购股数占总股本比例 0% 累计已回购金额 0万元 实际回购价格区间 0元/股~0元/股 一、 回购股份的基本情况 召开第十届董事会第十次会议，审议通过《关于以集中竞价交易方式回购 公司股份方案的议案》，同意公司使用自有资金以集中竞价交易方式回购 公司股份，用于员工持股计划或股权激励，回 ...

证券代码：600231 证券简称：凌钢股份 公告编号：临 2025-070 转债代码：110070 转债简称：凌钢转债 凌源钢铁股份有限公司 关于股份回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 回购方案首次披露日 2025 年 4 月 22 日 回购方案实施期限 待董事会审议通过后 12 个月 预计回购金额 5,000万元~10,000万元 □减少注册资本 √用于员工持股计划或股权激励 回购用途 □用于转换公司可转债 □为维护公司价值及股东权益 累计已回购股数 575.58万股 累计已回购股数占总股本比例 0.20% 累计已回购金额 1,078.75万元 实际回购价格区间 1.71元/股~2.07元/股 一、 回购股份的基本情况 （编 号：临 2025-051）和《凌源钢铁股份有限公司关于股份回购进展公告》（编号： 临 2025-056）。 二、 回购股份的进展情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号—回购股份》等相关规定，公司在回购期间，应当在每个月的 ...

Summary of Key Points Core Viewpoint - The company, Nanjing Novogene Bioinformatics Technology Co., Ltd., has announced a share repurchase plan aimed at enhancing employee stock ownership and incentivizing staff, with a total expected repurchase amount between 5 million and 10 million RMB [1][2]. Group 1: Share Repurchase Plan - The share repurchase plan was first disclosed on June 20, 2025, and will be implemented from June 19, 2025, to June 18, 2026 [1]. - The repurchase is intended for employee stock ownership plans or equity incentives, rather than reducing registered capital or converting convertible bonds [1]. - The company has already repurchased 40,000 shares, which accounts for 0.01% of the total share capital [1]. Group 2: Financial Details - The total amount spent on the repurchase so far is 973,800 RMB, with the repurchase price ranging from 24.26 RMB to 24.36 RMB per share [1]. - The maximum repurchase price is set at 30 RMB per share [1]. - The company plans to make repurchases based on market conditions during the specified period [2].

格隆汇9月1日丨新城市(300778.SZ)公布，截至2025年8月31日，公司通过股份回购专用证券账户以集中 竞价交易方式累计回购公司股份1,231,315股，占公司目前总股本的0.60%。最高成交价为16.88元/股， 最低成交价为9.93元/股，成交总金额为1304.33万元。 ...

格隆汇9月1日丨九典制药(300705.SZ)公布，截至2025年8月31日，公司通过股份回购专用证券账户以集 中竞价交易方式累计回购股份6,180,800股，占公司目前总股本的1.24%，最高成交价为18.44元/股，最 低成交价为14.51元/股，成交总金额为1.00亿元(不含交易费用)。 ...

Summary of Key Points Core Viewpoint - The company has initiated a share repurchase plan with a total expected amount between 150 million and 300 million RMB, aimed at enhancing shareholder value and supporting employee stock ownership plans [1][2]. Group 1: Share Repurchase Plan - The share repurchase plan was first disclosed on April 26, 2025, and is set to be implemented from April 25, 2025, to April 24, 2026 [1]. - The total amount expected for the repurchase is between 150 million and 300 million RMB [1]. - The repurchased shares will be used for employee stock ownership plans or equity incentives [1]. Group 2: Progress of Share Repurchase - As of the end of August 2025, the company has repurchased a total of 859,500 shares, which accounts for 0.04% of the total share capital [1]. - The total amount paid for the repurchased shares is 13,241,302 RMB, with a purchase price range between 13.96 RMB and 19.18 RMB per share [1]. - The highest purchase price recorded was 19.18 RMB per share, while the lowest was 13.96 RMB per share [1].

Group 1 - The company Guangdong Shenglu Communication Technology Co., Ltd. approved a share repurchase plan to buy back A-shares through the Shenzhen Stock Exchange for employee stock ownership or equity incentive plans [1] - The total amount for the repurchase is set between 142.90 million yuan and 285.80 million yuan, with a maximum repurchase price of 10.85 yuan per share [1] - The funding sources for the repurchase include self-owned funds and special loans for stock repurchase, with a duration of twelve months from the board's approval date [1] Group 2 - As of August 31, 2025, the company has repurchased a total of 4.6083 million shares, accounting for 0.49% of the total share capital, with a total payment of 49.9999 million yuan [1] - The repurchase price has not exceeded the upper limit, and the operation complies with regulations and the repurchase plan [1] - The company will continue to repurchase shares based on market conditions and will disclose progress in accordance with regulations [1]

Group 1 - The core viewpoint of the announcement is that Zhejiang Jianfeng Group Co., Ltd. has disclosed the progress of its share repurchase plan, which was approved by the board on April 18, 2025 [1][2]. - The company plans to use its own funds and self-raised funds for the share repurchase, with a total estimated amount between 20 million yuan and 40 million yuan [2]. - The repurchase period is set for 12 months from the date of board approval, starting from April 18, 2025, and the initial repurchase price was capped at 15.00 yuan per share, later adjusted to 12.42 yuan per share due to a rights distribution [2]. Group 2 - As of August 31, 2025, the company has not conducted any repurchase transactions, with a total of 0 shares repurchased, representing 0.00% of the total share capital [3]. - The company is required to announce the progress of the share repurchase within the first three trading days of each month, based on the status as of the end of the previous month [3]. - Zhejiang Jianfeng Group will adhere to relevant regulations and make repurchase decisions based on market conditions while fulfilling its information disclosure obligations [3].

登录新浪财经APP 搜索【信披】查看更多考评等级 广州集泰化工股份有限公司于2024年12月25日召开第四届董事会第七次会议，审议通过回购公司股份方 案，拟使用银行专项贷款资金、自有资金或其他自筹资金，以集中竞价交易方式回购部分A股股票，用 于员工持股计划或股权激励计划。回购金额不低于2000万元（含），不超过4000万元（含），回购价格 不超过8.57元/股（含），回购期限自董事会审议通过之日起不超过十二个月。 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 回购进展 截至2025年8月31日，公司以集中竞价方式回购股份800,000股，占公司目前总股本的比例为0.21%。回 购最高成交价为5.52元/股，最低成交价为4.86元/股，支付金额为 ...

Summary of Key Points Core Viewpoint - Hengyi Petrochemical has made significant progress in its share repurchase plan, indicating a commitment to enhancing shareholder value through strategic buybacks [1][3]. Group 1: Share Repurchase Plan Overview - The company approved a share repurchase plan on October 22, 2024, with a total repurchase amount between 125 million yuan and 250 million yuan, and a maximum repurchase price of 9.00 yuan per share [2]. - Following the completion of share cancellations, the maximum repurchase price was adjusted to 8.94 yuan per share [2]. Group 2: Latest Repurchase Progress - As of August 29, 2025, the company has repurchased a total of 29,240,840 shares, representing 0.81% of the total share capital [3]. - The highest transaction price during the repurchase was 6.62 yuan per share, while the lowest was 5.97 yuan per share, with a total transaction amount of approximately 184.9 million yuan (about 1.85 million yuan) [3]. Group 3: Compliance and Future Plans - The company has confirmed that the timing, pricing, and trading methods of the share repurchase comply with relevant regulations [4]. - Hengyi Petrochemical plans to continue the share repurchase based on market conditions and will fulfill its information disclosure obligations [4].